Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease

AIM: To assess tumor necrosis factor-α (TNF-α), infliximab (IFX) concentrations, and antibodies against IFX molecules in patients with inflammatory bowel disease (IBD) who develop loss of response, side effects, or allergic reaction during anti TNF-α therapy. METHODS: Blood samples of 36 patients wi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Pallagi-Kunstár, Éva, Farkas, Klaudia, Szepes, Zoltán, Nagy, Ferenc, Szűcs, Mónika, Kui, Róbert, Gyulai, Rolland, Bálint, Anita, Wittmann, Tibor, Molnár, Tamás
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2014
Konular:
Brief Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4009537/
https://ncbi.nlm.nih.gov/pubmed/24833846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i17.5031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller